Nf2 Related Schwannomatosis clinical trials

Explore recruiting nf2 related schwannomatosis clinical trials.

Recruiting nf2 related schwannomatosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nf2 Related Schwannomatosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(NFPET) ‘89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic neurofibromatosis type 2

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Nf2 Related Schwannomatosis trials by city

Nf2 Related Schwannomatosis in Toronto Nf2 Related Schwannomatosis in Vancouver Nf2 Related Schwannomatosis in Montreal Nf2 Related Schwannomatosis in Calgary Nf2 Related Schwannomatosis in Edmonton Nf2 Related Schwannomatosis in Ottawa Nf2 Related Schwannomatosis in Winnipeg Nf2 Related Schwannomatosis in Quebec City Nf2 Related Schwannomatosis in Hamilton Nf2 Related Schwannomatosis in Kitchener Nf2 Related Schwannomatosis in London Nf2 Related Schwannomatosis in Halifax Nf2 Related Schwannomatosis in New York Nf2 Related Schwannomatosis in Los Angeles Nf2 Related Schwannomatosis in Chicago Nf2 Related Schwannomatosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease